Pharmacological treatment of pure stress urinary incontinence: a narrative review

Mariam A Malallah 1, Tariq F Al-Shaiji

Affiliations

04 January 2015

-

doi: 10.1007/s00192-014-2512-9

Abstract

Introduction and hypothesis: Treatment escalation from conservative directly to surgical in the management of pure stress urinary incontinence (SUI) reveals a gap for effective pharmacological treatments. The introduction of a drug therapy would fill this gap and widen the treatment options. Nevertheless, various pharmaceutical agents have been used off-label and are being investigated and becoming more widely available. In this review, we examined the latest published data regarding pharmacotherapy used in the treatment of SUI.

Methods: We performed a literature review to evaluate the relevant studies pertaining to any pharmacotherapy used in the management of SUI, examining the English language literature.

Results: Currently, no drug exists that is approved by the food and drug administration for the management of SUI. A few oral pharmacological agents are occasionally used off-label. Lack of proven efficacy and high incidence of bothersome side effects of these agents limit their use. Duloxetine, a serotonin norepinephrine reuptake inhibitor, represents a major therapeutic advance for the treatment of SUI based on findings from a number of controlled clinical trials.

Conclusions: Several pharmacological agents have been used off-label and investigated for safety and efficacy, but none has demonstrated sufficient effectiveness to receive widespread verification for its use in the treatment of SUI.

Similar articles

Pharmacological agents used for the treatment of stress urinary incontinence in women.

Viktrup L, Bump RC.Curr Med Res Opin. 2003;19(6):485-90. doi: 10.1185/030079903125002126.PMID: 14594520 Review.

Pharmacotherapy for stress urinary incontinence : present and future options.

Zinner NR, Koke SC, Viktrup L.Drugs. 2004;64(14):1503-16. doi: 10.2165/00003495-200464140-00001.PMID: 15233589 Review.

[Pharmacological treatment for stress urinary incontinence in prostate cancer].

Puyol M, Collado A.Arch Esp Urol. 2009 Dec;62(10):882-8.PMID: 20068265 Review. Spanish.

[Update on medical treatment of female stress urinary incontinence].

Yazbeck C, Dhainaut C, Batallan A, Thoury A, Madelenat P.Gynecol Obstet Fertil. 2004 Jun;32(6):556-61. doi: 10.1016/j.gyobfe.2004.04.007.PMID: 15217571 Review. French.

New developments in the treatment of urinary incontinence.

Vella M, Robinson D, Cardozo L, Cartwright R.Minerva Urol Nefrol. 2006 Dec;58(4):299-310.PMID: 17268395 Review.

Cited by

Vaginal Laser Therapy for Female Stress Urinary Incontinence: New Solutions for a Well-Known Issue-A Concise Review.

Ruffolo AF, Braga A, Torella M, Frigerio M, Cimmino C, De Rosa A, Sorice P, Castronovo F, Salvatore S, Serati M.Medicina (Kaunas). 2022 Apr 4;58(4):512. doi: 10.3390/medicina58040512.PMID: 35454351 Free PMC article. Review.

The impact of vaginal cone therapy on stress urinary incontinence compared with transobturator tape.

Dur R, Akkurt İ, Coşkun B, Dur G, Çoşkun B, Ünsal M, Sivaslıoğlu AA.Turk J Obstet Gynecol. 2019 Sep;16(3):169-173. doi: 10.4274/tjod.galenos.2019.89137. Epub 2019 Oct 10.PMID: 31673469 Free PMC article.

Will future doctors know enough about stress urinary incontinence to provide proper preventive measures and treatment?

Witkoś J, Hartman-Petrycka M.Med Educ Online. 2019 Dec;24(1):1685635. doi: 10.1080/10872981.2019.1685635.PMID: 31662061 Free PMC article.

Amitriptyline accumulation in tissues after coated activated charcoal hemoperfusion-a randomized controlled animal poisoning model.

Jansen T, Hoegberg LCG, Eriksen T, Dalhoff KP, Belhage B, Johansen SS.Naunyn Schmiedebergs Arch Pharmacol. 2019 Oct;392(10):1285-1292. doi: 10.1007/s00210-019-01669-4. Epub 2019 Jun 11.PMID: 31187186

Efficacy and Safety of Incontinence Surgery According to the Surgeon's Specialty and Performance of a Preoperative Urodynamic Study.

Choi JB, Han KD, Ha US, Hong SH.Int Neurourol J. 2018 Dec;22(4):305-312. doi: 10.5213/inj.1836104.052. Epub 2018 Dec 31.PMID: 30599502 Free PMC article.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. BJOG. 2004 Dec;111 Suppl 1:10-4 - PubMed
  2.  
    1. Br J Obstet Gynaecol. 1999 Jul;106(7):711-8 - PubMed
  3.  
    1. Neurourol Urodyn. 2002;21(2):167-78 - PubMed
  4.  
    1. Acta Pharmacol Sin. 2008 Sep;29(9):1109-18 - PubMed
  5.  
    1. Int Urogynecol J. 2010 Jan;21(1):5-26 - PubMed
  6.  
    1. Urology. 1987 Oct;30(4):398-403 - PubMed
  7.  
    1. Am J Chin Med. 2014;42(4):817-31 - PubMed
  8.  
    1. BJOG. 2004 Mar;111(3):249-57 - PubMed
  9.  
    1. Obstet Gynecol. 2001 Sep;98(3):398-406 - PubMed
  10.  
    1. Life Sci. 2002 Aug 2;71(11):1227-36 - PubMed
  11.  
    1. Neuropsychopharmacology. 2001 Dec;25(6):871-80 - PubMed
  12.  
    1. BJU Int. 1999 Dec;84(9):923-47 - PubMed
  13.  
    1. BJU Int. 2004 Feb;93(3):311-8 - PubMed
  14.  
    1. Am J Chin Med. 2013;41(2):231-52 - PubMed
  15.  
    1. BJU Int. 2004 Jan;93(1):78-83 - PubMed
  16.  
    1. Urol Clin North Am. 1995 Aug;22(3):557-77 - PubMed
  17.  
    1. Int J Gynaecol Obstet. 2000 Oct;71(1):39-44 - PubMed
  18.  
    1. J Urol. 1997 Sep;158(3 Pt 1):875-80 - PubMed
  19.  
    1. BJU Int. 2004 Feb;93(3):324-30 - PubMed
  20.  
    1. Br J Obstet Gynaecol. 1983 Oct;90(10):919-33 - PubMed
  21.  
    1. Br Med J. 1980 Nov 8;281(6250):1243-5 - PubMed
  22.  
    1. Cochrane Database Syst Rev. 2001;(1):CD001407 - PubMed
  23.  
    1. World J Urol. 1997;15(5):268-74 - PubMed
  24.  
    1. Scand J Urol Nephrol. 1979;13(1):5-10 - PubMed
  25.  
    1. Obstet Gynecol. 1996 Nov;88(5):745-9 - PubMed
  26.  
    1. Am J Obstet Gynecol. 1981 Dec 1;141(7):817-20 - PubMed
  27.  
    1. Drugs. 1988 Apr;35(4):477-94 - PubMed
  28.  
    1. Cochrane Database Syst Rev. 2003;(2):CD001405 - PubMed
  29.  
    1. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9(3):145-50 - PubMed
  30.  
    1. J Clin Epidemiol. 2000 Nov;53(11):1150-7 - PubMed
  31.  
    1. BJU Int. 2004 May;93(7):1115 - PubMed
  32.  
    1. J Urol. 2005 May;173(5):1647-53 - PubMed
  33.  
    1. J Pharmacol Exp Ther. 1995 Aug;274(2):1014-24 - PubMed
  34.  
    1. Curr Med Res Opin. 2003;19(6):485-90 - PubMed
  35.  
    1. Urology. 1975 May;5(5):624-5 - PubMed
  36.  
    1. Maturitas. 2000 Aug 31;36(2):83-92 - PubMed
  37.  
    1. Int J Mol Sci. 2012 Nov 22;13(12):15523-35 - PubMed
  38.  
    1. Acta Obstet Gynecol Scand. 1984;63(3):257-60 - PubMed
  39.  
    1. J Urol. 2003 Oct;170(4 Pt 1):1259-63 - PubMed
  40.  
    1. N Engl J Med. 2000 Dec 21;343(25):1826-32 - PubMed
  41.  
    1. Am J Obstet Gynecol. 2002 Jul;187(1):40-8 - PubMed
  42.  
    1. J Urol. 1974 Jul;112(1):81-8 - PubMed
  43.  
    1. Obstet Gynecol. 2001 Jan;97(1):116-20 - PubMed
  44.  
    1. Minerva Ginecol. 2014 Oct;66(5):469-78 - PubMed
  45.  
    1. Nat Rev Urol. 2012 Nov;9(11):638-51 - PubMed

Page Navigation